SEC Form 4 · accession 0001162194-18-000101
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laura Clague
Director
Period of report
Oct 30, 2018
Accepted (ET)
Nov 1, 2018 · 8:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Oct 30, 2018 | A | 10,000 | $0.00 | A | 10,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $7.42 | Oct 30, 2018 | A | 15,000 | A | — | Oct 30, 2028 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit.
- F225% of the shares underlying the Restricted Stock Units will vest each anniversary after the date of grant on the same day of the month as the date of grant, subject to continued service as a director. The Reporting Person has deferred settlement of the Restricted Stock Units to occur within the thirty (30) day period immediately following the earlier to occur of: (a) the Reporting Person's termination of service with the Issuer; or (b) a Change of Control (as defined in the Company's 2011 Equity Incentive Plan).
- F325% of the shares underlying the Option will vest each anniversary after the date of grant on the same day of the month as the date of grant, subject to continued service as a director.